CRI Lifetree is devoted to promoting research in adult, adolescent and pediatric diabetes and related metabolic and endocrine disorders. Our multidisciplinary team approach to the execution of endocrinology research is committed to finding better treatments for the growing epidemic of diabetes. Each member of our research team is dedicated to providing our clients with clinical solutions that provide optimal benefit to their companies and consumers. With subject safety as our number one priority, we collect pristine and reproducible data that contributes to the development of safer and more effective treatments for metabolic and endocrine disorders.
About CRI Lifetree
CRI Lifetree is a product of the combination of CRI Worldwide and Lifetree Clinical Research. The two former leaders in clinical research combined forces in 2010 to create what is now a leading research organization that possesses exceptional talent and an abundance of study resources. Our merged organization is now one of the largest Specialized Research Organizations (SRO) in the United States with a combined 20 years of experience in clinical research. Our expanded Clinical Pharmacology capacity of over 190 beds also makes us one of the largest providers of patient population Phase I services in the nation. This combined with a clinical staff of some of the most prestigious and sought after medical professionals in the field makes us the best choice for clinical studies of varying nature.
Our research organization currently operates three research centers in the US. These centers are strategically located in Marlton, NJ, Philadelphia, PA and Salt Lake City, UT. If you would like to contact the center nearest you directly, please click here to find our contact page.To find out more about our services contact: email@example.com. We look forward to helping you achieve your clinical research goals through a safe and accurate endocrine study at one of our topnotch facilities.